Literature DB >> 35084305

The impact of SARS-CoV-2 infection in children with rheumatic/autoinflammatory diseases on immunosuppressive treatment: a single centre experience.

Despina N Maritsi1, Panaguotis Krepis2, George Vartzelis3, Aggeliki Syggelou4, Maria Tsolia5.   

Abstract

Entities:  

Year:  2022        PMID: 35084305

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  1 in total

1.  Comparisons of Clinical Features and Outcomes of COVID-19 between Patients with Pediatric Onset Inflammatory Rheumatic Diseases and Healthy Children.

Authors:  Fatih Haslak; Sevki Erdem Varol; Aybuke Gunalp; Ozge Kaynar; Mehmet Yildiz; Amra Adrovic; Sezgin Sahin; Gulsen Kes; Ayse Ayzit-Kilinc; Beste Akdeniz; Pinar Onal; Gozde Apaydin; Deniz Aygun; Huseyin Arslan; Azer Kilic-Baskan; Evrim Hepkaya; Ozge Meral; Kenan Barut; Haluk Cezmi Cokugras; Ozgur Kasapcopur
Journal:  J Clin Med       Date:  2022-04-09       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.